1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

Pfizer Inc. (NYSE: PFE) Share Price and News

$26.97 $-0.44 (-1.6%) 21 March 2026 at 7:00:00 am AEDT

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 21-03-2026, 07:00:00am AEDT
Current Price $26.97
Change $-0.44 (-1.6%)
Close Price $26.97
Open Price $27.41
Bid $26.89
Ask $27.04
Day Range $26.80 - $27.55
Year Range $20.92 - $27.94
Volume 66,805,681
Average Volume 45,208,697
Market Cap $263,198,126,084.00
Earnings Per Share $1.36

Pfizer Inc. (NYSE: PFE)
Latest News

Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
International Stock News

Why BioNTech trounced the Market on Tuesday

| Eric Volkman

Shareholders might be getting a small present from the company before long.

Read more »

The letters ETF on wooden cubes with golden coins on top of the cubes and on the ground
ETFs

3 ASX ETFs that could give investors easy exposure to the US markets

| Sebastian Bowen

Some easy ETFs for US exposure...

Read more »

A medical researcher in a white coat holds laboratory equipment and smiles.
International Stock News

Moderna's teen COVID-19 vaccine trial hits high marks

| Cory Renauer

The company should submit its request for the FDA to authorize the use of its vaccine in those 12 and…

Read more »

Medical asx share price fall represented by worried looking patient awaiting vaccine injection
International Stock News

Australia eyes Moderna (NASDAQ:MRNA) COVID-19 vaccine delivery

| Aaron Teboneras

The Moderna Inc (NASDAQ: MRNA) share price slipped overnight, despite the company announcing a deal with the Australian government.

Read more »

a doctor looking up at question marks
Healthcare Shares

What the Federal Budget could mean for CSL (ASX:CSL) shares

| Brooke Cooper

How shares in Australia's only vaccine manufacturer CSL Limited (ASX: CSL) might be affected by 2 key Federal Budget initiatives.

Read more »

health prffesional giving someone a vaccine
International Stock News

Pfizer and BioNTech's COVID-19 vaccine authorized by the FDA for adolescents

| Brian Orelli, PhD

Parents are pleased, but the move won't change much for the drug companies from a financial perspective.

Read more »

woman carrying out an experiment with a pipette and petri dish
International Stock News

If Pfizer's vaccine is a winner, why did this analyst downgrade its stock?

| Eric Volkman

Mizuho Securities' Vamil Divan expresses concern about the company's post-coronavirus future.

Read more »

Female patient receives Pfizer covid vaccine administered by female doctor
International Stock News

Moderna just made the Pfizer vaccine's biggest weakness an even bigger one

| Adria Cimino

Both vaccines do an impressive job of providing protection against COVID-19. But Moderna's is much easier to get from production…

Read more »

People marching and holding up anti covid vaccine signs
Healthcare Shares

Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?

| Marc Sidarous

Only 40% of Australians are willing to have the AstraZeneca vaccine. What, if anything, could this mean for CSL Limited…

Read more »

asx share price rebound represented by wooden blocks spelling rebound with coins on top
Healthcare Shares

Why the CSL (ASX:CSL) share price has rebounded 13% since March

| Aaron Teboneras

The CSL Limited (ASX: CSL) share price is rebounding following recent developments. We take a closer look in what could…

Read more »

woman waering face mask holding vial of covid-19 vaccine
Share Market News

Wesfarmers' (ASX:WES) Bunnings open to hosting COVID vaccine hubs

| Marc Sidarous

Wesfarmers Ltd (ASX: WES) subsidiary, Bunnings, is open to the government using its car parks for COVID-19 mass vaccination hubs.…

Read more »

asx share associated with COVID vaccine represented by lab tech drawing down syringe
International Stock News

Pfizer to develop mRNA vaccines without BioNTech

| Cory Renauer

The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines.

Read more »

Profile

since

Note